after its recent quarterly results it fell a lot. its a very good stock for the swing trade. i have mentioned its targets and they are good support for those earlier a month ago, i had posted its 5 waves. and this time i have extended it till its IPO PRICE. its a bit sad, that it came down this low. but its good to buy in dip. i am aiming for the targets...
stock retraced 100%..........feel its a wonderful buy!
NSE:GLAND stock is forming a bullish harami pattern u can buy for a BTST
the stock will have a good impulse move, it has corrected a lot, one can earn about 90% from taking a swing trade. the stock has reached at a price of its IPO's time only. good RSI DIVERGENCE is forming. stock price targets are too mentioned. at last: have a look on moving averages too.
Gland pharma looking good to buy after this correction 2700 and 3000 targets can be expected Dis . For educational purpose
Strongly buy at 2502 target will be 2550 It will be fire just wait and watch
Trend Line Breakout Done Bottom Formation Done 1st HL Formed Currently in Accumulation Bullish above 2300-2315 Sl Below 2460 Tgts 2420-2500-2700-2850
galnd buy on dip 3100-3000 sl 2780 hold buy sooon big move
Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA |...
Daily seen double bottom and rsi divergence buy at Cmp(3300)Sl will at 3200 for 3450 3500 ++
The stock has broken out and retested, therefore may undergo a reversal rally. Trade is supported by brokerage calls and Supports Nearby. Risk Reward Ratio - 2:1 SL is placed below support zone & the lower trendline. The target is placed near resistance.
The stock has reached lower trendline and may undergo a reversal rally. Trade is supported by brokerage calls and Supports Nearby. Risk Reward Ratio - 3:1 SL is placed below support zone & the lower trendline. The target is placed near resistance.
Price coming out of a range, Fundamentals are good to enter
Good evening friends welcome we are today discussing about Gland pharma please see the video for detailed analysis. You can ask any queries of stock from us. We will be happy to share our view. Regards.
The stock has reached lower trendline and may undergo a reversal rally. Trade is supported by brokerage calls and Supports Nearby. Risk Reward Ratio - 3:1 SL is placed below support zone & the lower trendline. The target is placed near resistance.
possible upmove till 4250 if close above 3727 entry at 3645 & SL below 3490...
Revenue from operations in H1 FY22 stood at ₹2,234.4 crore as compared to ₹1,715.7 crore in H1 FY21, witnessing a growth of 30.2% YoY on account of launch of new products and growth in existing products. • PBT (profit before tax) in Q2 FY22 was ₹400.7 crore v/s ₹292.6 crore in Q2 FY21, registering a growth of 36.9% YoY, due to operating leverage benefit and higher...
Gland had been sliding and then formed a wedge like pattern and has now BO'd just an hour ago...Targets marked. Gland is one of the leading Pharma companies when it comes to producing injectables..and has pretty good fundamentals..so you could think long term..